Novel 3-Substituted 8-Methoxycoumarin Derivatives as Anti-Breast Cancer Drugs
Scientists have been interested in hybrid coumarin derivatives due to their wide clinical anticancer use. Herein, ethyl 8-methoxycoumarin-3-carboxylate (Compound <b>1</b>) served as the starting material for the synthesis of a series of novel hybrid coumarin derivatives (Compounds <b&...
Main Authors: | Tarfah Al-Warhi, Ola A. Abu Ali, Leena S. Alqahtani, Eman Abo-Elabass, Mohammed El Behery, Atef E. Abd El-Baky, Mohamed Samir A. Zaki, Eman Fayad, Eman M. Radwan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-06-01
|
Series: | Crystals |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4352/13/7/1037 |
Similar Items
-
A Liquid Chromatographic Analysis of Gemifloxacin in Pharmaceutical Preparations Using 4-bromomethyl-7-methoxycoumarin Reagent
by: Cem ÖNAL
Published: (2021-03-01) -
4-Hydroxy-7-Methoxycoumarin Inhibits Inflammation in LPS-activated RAW264.7 Macrophages by Suppressing NF-κB and MAPK Activation
by: Jin Kyu Kang, et al.
Published: (2020-09-01) -
Unveiling the antitumor potential of novel N-(substituted-phenyl)-8-methoxycoumarin-3-carboxamides as dual inhibitors of VEGFR2 kinase and cytochrome P450 for targeted treatment of hepatocellular carcinoma
by: Eman M. Radwan, et al.
Published: (2023-08-01) -
Novel 8-Methoxycoumarin-3-Carboxamides with potent anticancer activity against liver cancer via targeting caspase-3/7 and β-tubulin polymerization
by: Ahmad Alzamami, et al.
Published: (2023-12-01) -
Sulfatase 1 and sulfatase 2 as novel regulators of macrophage antigen presentation and phagocytosis
by: Hyun-Je Kim, et al.
Published: (2021-10-01)